Leukemia Clinical Trials

50 trials recruiting in Canada.

Cancer

RecruitingDrugDeviceBehavioralOlder adultsHealthy volunteers

50 trials · showing 30

Comparing Biospecimen Collection with Bone Marrow Aspiration for chronic lymphocytic leukemia

Explore this study →

There are 2 groups in this study. Group A, the comparison group, receives one or more of: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Obinutuzumab, Questionnaire Administration and Venetoclax. Group B receives one or more of: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Obinutuzumab, Questionnaire Administration and Venetoclax.

Sites in Halifax, Montreal and 6 more cities

  • Phase 3
  • 2 groups
  • Sites in Vancouver, Winnipeg and 6 more cities
  • Recruiting

Official title: Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia · National Cancer Institute (NCI)

Get matched to the best-fit trials

Answer a few questions and we'll find the closest matches for leukemia.

Comparing Allopurinol with Doxorubicin for b acute lymphoblastic leukemia

Explore this study →

There are 2 groups in this study. Group A, the comparison group, receives one or more of: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Bone Marrow Aspiration and Biopsy, Cyclophosphamide, Mercaptopurine, Rituximab, Thioguanine and Laboratory Biomarker Analysis. Group B receives Inotuzumab Ozogamicin, together with one or more of: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Bone Marrow Aspiration and Biopsy, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine and Laboratory Biomarker Analysis.

Sites in Calgary, Halifax and 3 more cities

  • Phase 3
  • 2 groups
  • Sites in Calgary, Winnipeg and 3 more cities
  • Recruiting

Official title: Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia · Alliance for Clinical Trials in Oncology

Comparing 3 approaches for acute myeloid leukemia

Explore this study →

There are 3 groups in this study. Group A receives Cytarabine and Venetoclax, together with one or more of: Biospecimen Collection, Bone Marrow Aspiration, Daunorubicin Hydrochloride, Echocardiography Test and Multigated Acquisition Scan. Group B receives Azacitidine and Venetoclax, together with one or more of: Biospecimen Collection, Bone Marrow Aspiration, Echocardiography Test and Multigated Acquisition Scan. Group C, the comparison group, receives Cytarabine, together with one or more of: Biospecimen Collection, Bone Marrow Aspiration, Daunorubicin Hydrochloride, Echocardiography Test and Multigated Acquisition Scan.

Sites in Montreal, Calgary and 6 more cities

  • Phase 2
  • 3 groups
  • Sites in Calgary, Edmonton and 6 more cities
  • Recruiting

Official title: Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia · National Cancer Institute (NCI)

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Leukemia trials near you.

Leukemia
Want matched now instead? →
← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.